Key points in #remdesivir study: "not associated with a difference in time to clinical improvement" "not associated with statistically significant clinical benefits." 66% of patients on remdesivir experienced adverse events. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31022-9/fulltext #news #CCPVirus #pandemic